ArticleCureus2025
Coexistence of Hodgkin's Lymphoma and Tuberculosis in Two Young Adults: Diagnostic and Management Challenges.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB), primarily a pulmonary disease, can affect other organs and has been linked to an increased risk of Hodgkin's lymphoma (HL). Both conditions share similar clinical manifestations, including fever, night sweats, and weight loss, making diagnosis challenging. We report two cases of HL with a history of TB infection in childhood. The first case involved a 20-year-old female presenting with chronic cough, dyspnea, and weight loss. Imaging revealed an anterior mediastinal mass, and a biopsy confirmed classical HL. The patient received ABVD (doxorubicin, bleomycin, vincristine, and dacarbazine) chemotherapy followed by radiotherapy, leading to partial tumor regression. However, signs of TB reactivation emerged, prompting anti-TB treatment, which alleviated the symptoms. The second case involved an 18-year-old male with a persistent cervical mass initially misdiagnosed as TB lymphadenitis. Despite prolonged anti-TB therapy, the mass persisted and was later diagnosed as HL through immunohistochemistry. He underwent ABVD chemotherapy and radiotherapy, resulting in a favorable response. Together, TB and HL can coexist, complicating diagnosis and management. Clinicians should prioritize thorough diagnostic workups, including histopathology and immunohistochemistry, in patients with persistent lymphadenopathy or atypical TB presentations. Early differentiation between TB and HL is critical to ensure timely and appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.